Autopsy report · NCT00990119

High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)

“Pilot enrollment criteria did not yield intended population.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Vapotherm, Inc.

Sponsor type

Industry

Conditions

Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency

Interventions

Vapotherm High Flow Therapy; Non-invasive positive pressure ventilation

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI
  “Study did not meet enrollment goals.” (71% match in meaning)
• Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED)
  “Enrollment did not progress as anticipated. No participants enrolled.” (71% match in meaning)
• Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques
  “Enrollment goal was not met.” (71% match in meaning)
• Remote Ischemic Conditioning in Traumatic Brain Injury
  “No eligible participants were enrolled.” (70% match in meaning)
• Pregabalin for Central Sensitization in TKA
  “Enrollment lower than anticipated; none of the subjects completing the study.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.